Author:
Radhakrishnan Vivek, ,S. Swanson Mark,K. Sinha Uttam
Publisher
American Institute of Mathematical Sciences (AIMS)
Reference32 articles.
1. Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer;Temam S, Kawaguchi H, El-Naggar AK, et al.; J Clin Oncol,2007
2. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck;Bonner JA, Harari PM, Giralt J;N Engl J Med,2006
3. Structural basis for inhibition of the epidermal growth factor receptor by cetuximab;Li S, Schmitz KR, Jeffrey PD, et al.;Cancer Cell,2005
4. FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab;Zhang W, Gordon M, Schultheis AM, et al.; J Clin Oncol,2007
5. Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study;Burtness B, Goldwasser MA, Flood W, et al.; J Clin Oncol,2005
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献